GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Post ERCP-Induced Perforation

Post ERCP-Induced Perforation

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated August 1, 2025

Quick Answer

Endoscopic retrograde cholangiopancreatography (ERCP)-induced perforation is a rare but serious complication that requires prompt diagnosis and appropriate management to minimize morbidity and mortality. Management strategies are guided by the type and severity of the perforation, the patient's clinical status, and the timing of diagnosis.


Endoscopic retrograde cholangiopancreatography (ERCP)-induced perforation is a rare but serious complication that requires prompt diagnosis and appropriate management to minimize morbidity and mortality. Management strategies are guided by the type and severity of the perforation, the patient's clinical status, and the timing of diagnosis. Below is a detailed discussion of management strategies based on the context provided and general clinical guidelines:

---

### **1. Classification of ERCP-Induced Perforations**

ERCP-induced perforations are classified using the **Stapfer classification**, which categorizes perforations into four types:

  • **Type I**: Perforation of the duodenum or stomach due to guidewire or scope-related injury.
  • **Type II**: Periampullary perforations often caused by sphincterotomy, the most common type identified in the Japanese cohort study.
  • **Type III**: Perforation related to a ductal injury (e.g., bile or pancreatic duct).
  • **Type IV**: Retroperitoneal air without clear evidence of a perforation.

Management strategies depend on the type and severity of perforation.

---

### **2. Importance of Early Diagnosis**

  • **Intraprocedural Recognition**: Early identification during the ERCP procedure is critical for improving outcomes. Signs may include extraluminal air on fluoroscopy, bile leakage, or patient instability.
  • **Postprocedural Diagnosis**: Delayed diagnosis can occur if symptoms such as abdominal pain, fever, or signs of peritonitis develop after the procedure. A high index of suspicion is needed.

---

### **3. Imaging for Diagnosis**

  • **CT Scan**: A key tool for confirming the presence of perforation, assessing the extent of injury, and identifying complications such as retroperitoneal air or fluid collections.
  • **Fluoroscopy**: During the procedure, fluoroscopic findings such as extraluminal contrast can suggest perforation.

---

### **4. Management Strategies**

Management is tailored to the type of perforation, clinical presentation, and imaging findings. Broadly, the options include **conservative management**, **endoscopic therapy**, and **surgical intervention**:

#### **A. Conservative Management**

  • Suitable for small, contained perforations without signs of sepsis or peritonitis.
  • Includes:
  • Nil per os (NPO) or bowel rest.
  • Intravenous fluids to maintain hydration.
  • Broad-spectrum antibiotics to prevent or treat infection.
  • Pain control.
  • Serial clinical and radiologic monitoring.
  • Often used for Type III and Type IV perforations or stable patients with minimal leakage.

#### **B. Endoscopic Therapy**

  • **Primary Strategy for Type II Perforations**: The Japanese cohort study highlights the effectiveness of endoscopic therapy for periampullary perforations (Type II), which are the most common.
  • Techniques include:
  • **Endoscopic clipping**: To close the perforation.
  • **Stent placement**: To divert bile or pancreatic secretions and facilitate healing.
  • **Fibrin glue or sealants**: To seal the perforation in some cases.
  • Benefits of Endoscopic Therapy:
  • Shorter hospital stays.
  • Faster recovery.
  • Favorable outcomes compared to surgery.

#### **C. Surgical Intervention**

  • Reserved for cases where conservative or endoscopic management fails, or for large, unstable perforations (e.g., Type I injuries).
  • Indications include:
  • Generalized peritonitis.
  • Hemodynamic instability.
  • Large or uncontained perforations.
  • Failure of non-surgical management.
  • Surgical options may involve primary repair, resection, or drainage of abscesses.

---

### **5. Post-Management Considerations**

  • **Close Monitoring**: Patients require careful follow-up to detect complications such as abscess formation, sepsis, or delayed healing.
  • **Nutritional Support**: May be necessary for patients requiring prolonged bowel rest.
  • **Prevention in Future Procedures**: For patients requiring repeat ERCP, careful technique and risk mitigation strategies should be employed.

---

### **6. Key Takeaways from the Japanese Cohort Study**

  • **Incidence**: Duodenal perforation occurred in 0.12% of cases, with Type II being the most common.
  • **Endoscopic Therapy**: Associated with better outcomes, shorter hospital stays, and faster recovery compared to surgery.
  • **Timely Diagnosis**: Early recognition, particularly intraprocedural, was critical to improving prognosis.
  • **Surgery**: Should be reserved for selected cases where other strategies are insufficient.

---

### **7. Conclusion**

The management of ERCP-induced perforation requires a multidisciplinary approach involving gastroenterologists, surgeons, and radiologists. Early diagnosis and timely intervention are essential. Endoscopic therapy is the preferred strategy for most cases, particularly Type II perforations, while surgery is reserved for severe or refractory cases. Adherence to these principles can optimize outcomes and minimize complications.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer